ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,660Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 570

$1.38M Total Retail Price of All Prescriptions

Rank: 11 out of 570

421 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 16,036 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

50% of this provider’s prescriptions were for brand-name drugs, compared to an average of 52%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $124 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 636 603 1 7
QVAR 619 588 10 2 40
ATORVASTATIN CALCIUM 609 580 3 20
ALENDRONATE SODIUM 491 479 4 28
SIMVASTATIN 457 441 5 6
DIOVAN 448 436 6 27
OMEPRAZOLE 409 371 7 5
DIOVAN HCT 387 370 8 83
LEVOTHYROXINE SODIUM 381 366 9 8
NEXIUM 378 377 10 45
CRESTOR 362 362 11 60
SYMBICORT 358 350 12 13
SPIRIVA 336 307 13 1
ADVAIR DISKUS 323 323 14 2
ATENOLOL 322 310 15 22
ZOLPIDEM TARTRATE 274 264 16 17
TRAMADOL HCL 249 226 17 31
LOSARTAN POTASSIUM 247 219 18 23
LOSARTAN-HYDROCHLOROTHIAZIDE 243 243 19 111
CARVEDILOL 229 229 20 33
SINGULAIR 219 217 21 15
METOPROLOL SUCCINATE 209 206 22 44
SERTRALINE HCL 204 183 23 61
DEXILANT 200 195 24 193
LISINOPRIL 186 178 25 11
METFORMIN HCL 186 174 25 14
PANTOPRAZOLE SODIUM 179 179 27 21
FAMOTIDINE 176 176 28 41
JANUMET 171 159 29 190
DONEPEZIL HCL 169 169 30 35
LIPITOR 167 166 31 139
ESCITALOPRAM OXALATE 167 166 31 72
HYDROCHLOROTHIAZIDE 160 147 33 26
PRAVASTATIN SODIUM 138 138 34 43
ACIPHEX 134 132 35 245
GABAPENTIN 132 117 36 25
POTASSIUM CHLORIDE 131 131 37 24
CYMBALTA 131 117 37 93
ZETIA 130 117 39 135
FUROSEMIDE 129 129 40 10
TAMSULOSIN HCL 129 129 40 37
DOXAZOSIN MESYLATE 128 128 42 110
JANUVIA 118 118 43 58
NAMENDA 117 117 44 50
CELEBREX 116 116 45 102
MONTELUKAST SODIUM 102 102 46 29
NASONEX 100 100 47 57
DILTIAZEM ER 98 98 48 186
BENAZEPRIL HCL 97 97 49 42
PLAVIX 96 91 50 68
CITALOPRAM HBR 89 65 51 82
CLONIDINE HCL 87 87 52 49
PREDNISONE 86 86 53 3
LEVOFLOXACIN 84 83 54 32
TRICOR 79 79 55 151
METOPROLOL TARTRATE 78 71 56 18
ACTOS 76 76 57 146
SINGLE USE SWAB 75 75 58 299
WARFARIN SODIUM 74 74 59 16
PROAIR HFA 73 72 60 4
BUSPIRONE HCL 72 72 61 174
FLUTICASONE PROPIONATE 72 72 61 19
DIGOXIN 71 71 63 46
CLOPIDOGREL 71 63 63 48
NORTRIPTYLINE HCL 68 68 65 255
FORADIL 68 68 65 164
FLUOXETINE HCL 67 67 67 94
LEXAPRO 66 64 68 176
ALLOPURINOL 64 64 69 55
DETROL LA 62 62 70 317
ISOSORBIDE MONONITRATE ER 61 61 71 89
LOVAZA 59 47 72 153
SYNTHROID 57 45 73 134
AZITHROMYCIN 56 53 74 12
IBANDRONATE SODIUM 55 54 75 260
MECLIZINE HCL 54 54 76 195
THEOPHYLLINE ANHYDROUS 53 44 77 47
VOLTAREN 50 50 78 165
CLOTRIMAZOLE-BETAMETHASONE 50 50 78 152
VENTOLIN HFA 50 43 78 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.